RE:RE:RE:RE:RE:RE:A raise?Thank you CS for your many contributions, far more than anything I can add. And I didn't want to sound too dismissive of any competition only to say that when trying achieve what TLT is trying to do there will always be many players. Most of us like our chances with TLT and as you say the fact that they may have a solution for treating not only NMIBC but many other cancers gives them a leg up on most competitors.
Wealthy or very comfortable I think we will be very happy in the end.
CancerSlayer wrote:
StevenBirch wrote: If this message board were a stock and you put it on a chart you could make a ton of money because it is so repeatable.
We get a good report, people are feeling good, the stock rises and then someone (manipulators) says that's enough and it trades sideways to down a little. Same old same old.
And here the pattern is the same, as soon as it peaks the same old stories come out - first it's the dreaded competition, then it's financing and I'm waiting for the grandaddy of them all early next week - the reverse split. It never ends.
I get it that between reports it can get boring but Eog and Enrique (and others) provide us with enough material to keep everyone interested. And the discussions that result from those posts are also very informative but then some chime in with their veiled pessimism and it's not always newbies, you just ignore them.
Can someone please say that competition isn't a problem because either there isn't any REAL competition or there is room for more than one company and we can still all get rich? And I think enough people have put the financing question or worry about it to bed - don't beat a dead horse. And anyone who mentions reverse split should go on immediate ignore because they are not a serious person.
Feb 28 is too far away.
Totally agree SB....my simplistic view:
Competition is a reality & I personally like to stay informed of all real/potential competition...just helps to keep my sometimes exaggerated expectations in check...tired of being disappointed. However, for many cancer indications (including higher-risk/resistant NMIBC, GBM & NSCLC to name a very few), the competition seems very limited & the timing for TLT's unique approach couldn't be any better.
For the current indication, the real competition has yet to be approved/commercialized imo, & we are currently on a path to to be part of what appears to be an elite/very small group...there is at least 1 or 2 other treatments in development imo that look promising. But as with any product competition, it will come down to satisfying product quality, pricing & customer satisfaction that will separate the best from the rest. Unlike the competition, I think TLT has the real potential to more adeptly meet all of the above.
I'm not looking to get wealthy on one investment, just "very" comfortable....but I'm definitely due for a BIG surprise ; ). Good luck & thanks SB for you knowledgeable contributions to this board.